Wall Street 3 Merger and Acquisitions Stock Stories to Check Out on Friday
Wall Street 7/12 Google to Verify
3 Merger and Acquisitions Stock Stories to Check Out on Friday
By Mark Lawson | More Articles
July 12, 2013
Page 3 of 3
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN): Current price $113.7
Knowledgeable sources say that Roche Holding is searching out billions of dollars in financing for a potential takeover of Alexion, and that Roche has been in sporadic contact with Alexion for months. Alexion had a market value of approximately $20 billion before Friday, and has one approved drug: Soliris, which is used for the treatment of rare blood diseases. Such a takeover would be Roche’s biggest since it bought the portion of Genentech Inc. it did not already own for $46.8 billion four years ago, marking the biggest biotechnology deal on record, according to data compiled by Bloomberg.